Indocyanine green and laser light for the treatment of AIDS-associated cutaneous Kaposi's sarcoma
1998

Using Indocyanine Green and Laser Light to Treat Kaposi's Sarcoma in AIDS Patients

Sample size: 3 publication Evidence: low

Author Information

Author(s): C Abels, S Karrer, W Baumler, AE Goetz, M Landthaler, R-M Szeimies

Primary Institution: Department of Dermatology, University of Regensburg; Institute of Anaesthesiology, University of Munich, Germany

Hypothesis

ICG localized in the microvasculature and extravascular space of solid tumours might be used as a photosensitizer in combination with irradiation by a diode laser.

Conclusion

AIDS-associated Kaposi's sarcoma can be effectively treated using ICG-mediated phototherapy with good cosmetic results.

Supporting Evidence

  • Complete remission of Kaposi's sarcoma was achieved in 16 lesions treated with the appropriate dosage and timing of ICG and laser.
  • Biopsies revealed necrosis of the tumor 24 hours after therapy and complete remission 4 weeks after treatment.
  • Cosmetic results were very good, with minimal scarring observed.

Takeaway

Doctors used a special dye and laser to help treat skin cancer in people with AIDS, and it worked really well without causing many side effects.

Methodology

Three patients with AIDS-associated Kaposi's sarcoma were treated with ICG and laser light, and their responses were evaluated over time.

Limitations

The study involved a small number of patients and was a pilot study.

Participant Demographics

Three homosexual men aged 33, 34, and 67 years.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication